- Published on
Pathology - Diabetes Insipidus
Large amounts of diluted urine (up to 20 L/d) are passed due to a deficit in pee concentrating ability caused by a relative lack of vasopressin release from the posterior pituitary. Patients need to drink a lot of water to make up for the water they lose through urine in order to maintain normal plasma osmolarity. Hypernatremia and dehydration ensue if the patient lacks access to enough drinking water or has a malfunctioning thirst mechanism. Vasopressin secretion can be lost due to secondary causes like infection, trauma, or tumor metastasis, or it might have a fundamental cause like autoimmune illness. V2-receptor agonists, such as desmopressin, can be used to treat patients with central DI since their renal tubules are healthy and responsive to vasopressin. Because corticosteroid drugs increase the excretion of free water, the patient's continuous corticosteroid treatment is a complicating complication. Nephrogenic DI is characterized by comparable symptoms but is caused by a relative absence of renal responsiveness to vasopressin, which the pituitary gland continues to secrete regularly. Both congenital and acquired conditions, such as pyelonephritis, renal amyloidosis, potassium depletion, and lithium therapy, can result in nephrogenic DI. Vasopressin derivatives are not effective in treating nephrogenic DI.
Large amounts of diluted urine (up to 20 L/d) are passed due to a deficit in pee concentrating ability caused by a relative lack of vasopressin release from the posterior pituitary. Patients need to drink a lot of water to make up for the water they lose through urine in order to maintain normal plasma osmolarity. Hypernatremia and dehydration ensue if the patient lacks access to enough drinking water or has a malfunctioning thirst mechanism. Vasopressin secretion can be lost due to secondary causes like infection, trauma, or tumor metastasis, or it might have a fundamental cause like autoimmune illness. V2-receptor agonists, such as desmopressin, can be used to treat patients with central DI since their renal tubules are healthy and responsive to vasopressin. Because corticosteroid drugs increase the excretion of free water, the patient's continuous corticosteroid treatment is a complicating complication. Nephrogenic DI is characterized by comparable symptoms but is caused by a relative absence of renal responsiveness to vasopressin, which the pituitary gland continues to secrete regularly. Both congenital and acquired conditions, such as pyelonephritis, renal amyloidosis, potassium depletion, and lithium therapy, can result in nephrogenic DI. Vasopressin derivatives are not effective in treating nephrogenic DI.
0 Comments
